1. Home
  2. ERNA vs AMBO Comparison

ERNA vs AMBO Comparison

Compare ERNA & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERNA
  • AMBO
  • Stock Information
  • Founded
  • ERNA 2018
  • AMBO 2000
  • Country
  • ERNA United States
  • AMBO United States
  • Employees
  • ERNA N/A
  • AMBO N/A
  • Industry
  • ERNA Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • ERNA Health Care
  • AMBO Real Estate
  • Exchange
  • ERNA Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • ERNA 10.2M
  • AMBO 8.3M
  • IPO Year
  • ERNA N/A
  • AMBO 2010
  • Fundamental
  • Price
  • ERNA $1.37
  • AMBO $3.36
  • Analyst Decision
  • ERNA
  • AMBO
  • Analyst Count
  • ERNA 0
  • AMBO 0
  • Target Price
  • ERNA N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • ERNA 38.8K
  • AMBO 39.9K
  • Earning Date
  • ERNA 08-13-2025
  • AMBO 08-05-2025
  • Dividend Yield
  • ERNA N/A
  • AMBO N/A
  • EPS Growth
  • ERNA N/A
  • AMBO N/A
  • EPS
  • ERNA N/A
  • AMBO 0.69
  • Revenue
  • ERNA $488,000.00
  • AMBO $9,699,000.00
  • Revenue This Year
  • ERNA N/A
  • AMBO N/A
  • Revenue Next Year
  • ERNA N/A
  • AMBO N/A
  • P/E Ratio
  • ERNA N/A
  • AMBO $4.91
  • Revenue Growth
  • ERNA 201.24
  • AMBO 23.73
  • 52 Week Low
  • ERNA $1.32
  • AMBO $1.00
  • 52 Week High
  • ERNA $27.60
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • ERNA 32.80
  • AMBO 52.21
  • Support Level
  • ERNA $1.43
  • AMBO $3.22
  • Resistance Level
  • ERNA $1.56
  • AMBO $3.78
  • Average True Range (ATR)
  • ERNA 0.11
  • AMBO 0.51
  • MACD
  • ERNA -0.00
  • AMBO -0.03
  • Stochastic Oscillator
  • ERNA 10.64
  • AMBO 30.28

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: